234 related articles for article (PubMed ID: 23087298)
1. Remote ischemic preconditioning in percutaneous coronary revascularization: a double-blind randomized controlled clinical trial.
Ghaemian A; Nouraei SM; Abdollahian F; Naghshvar F; Giussani DA; Nouraei SA
Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):548-54. PubMed ID: 23087298
[TBL] [Abstract][Full Text] [Related]
2. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
[TBL] [Abstract][Full Text] [Related]
3. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention.
Ahmed RM; Mohamed el-HA; Ashraf M; Maithili S; Nabil F; Rami R; Mohamed TI
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E647-53. PubMed ID: 23404916
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action.
Rentoukas I; Giannopoulos G; Kaoukis A; Kossyvakis C; Raisakis K; Driva M; Panagopoulou V; Tsarouchas K; Vavetsi S; Pyrgakis V; Deftereos S
JACC Cardiovasc Interv; 2010 Jan; 3(1):49-55. PubMed ID: 20129568
[TBL] [Abstract][Full Text] [Related]
5. Remote ischemic preconditioning in cyanosed neonates undergoing cardiopulmonary bypass: a randomized controlled trial.
Jones BO; Pepe S; Sheeran FL; Donath S; Hardy P; Shekerdemian L; Penny DJ; McKenzie I; Horton S; Brizard CP; d'Udekem Y; Konstantinov IE; Cheung MM
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1334-40. PubMed ID: 23414626
[TBL] [Abstract][Full Text] [Related]
6. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
7. Does Remote Ischaemic Preconditioning Protect Kidney and Cardiomyocytes After Coronary Revascularization? A Double Blind Controlled Clinical Trial.
Nouraei SM; Baradari AG; Jazayeri A
Med Arch; 2016 Oct; 70(5):373-378. PubMed ID: 27994300
[TBL] [Abstract][Full Text] [Related]
8. A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol.
Young PJ; Dalley P; Garden A; Horrocks C; La Flamme A; Mahon B; Miller J; Pilcher J; Weatherall M; Williams J; Young W; Beasley R
Basic Res Cardiol; 2012 May; 107(3):256. PubMed ID: 22406977
[TBL] [Abstract][Full Text] [Related]
9. Repeated Episodes of Remote Ischemic Preconditioning for the Prevention of Myocardial Injury in Vascular Surgery.
Thomas KN; Cotter JD; Williams MJ; van Rij AM
Vasc Endovascular Surg; 2016 Apr; 50(3):140-6. PubMed ID: 27075990
[TBL] [Abstract][Full Text] [Related]
10. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
[TBL] [Abstract][Full Text] [Related]
11. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial.
Hoole SP; Heck PM; Sharples L; Khan SN; Duehmke R; Densem CG; Clarke SC; Shapiro LM; Schofield PM; O'Sullivan M; Dutka DP
Circulation; 2009 Feb; 119(6):820-7. PubMed ID: 19188504
[TBL] [Abstract][Full Text] [Related]
13. Remote Ischemic Preconditioning in High-risk Cardiovascular Surgery Patients: A Randomized-controlled Trial.
Coverdale NS; Hamilton A; Petsikas D; McClure RS; Malik P; Milne B; Saha T; Zelt D; Brown P; Payne DM
Semin Thorac Cardiovasc Surg; 2018; 30(1):26-33. PubMed ID: 29055710
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome following remote ischemic postconditioning during percutaneous coronary interventions-the RIP-PCI trial long-term follow-up.
Lavi S; Abu-Romeh N; Wall S; Alemayehu M; Lavi R
Clin Cardiol; 2017 May; 40(5):268-274. PubMed ID: 28075499
[TBL] [Abstract][Full Text] [Related]
15. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
[TBL] [Abstract][Full Text] [Related]
16. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
[TBL] [Abstract][Full Text] [Related]
17. Remote ischemic preconditioning of the heart: Combining lower limb ischemia and electronic stimulation of the gastrocnemius muscle.
Reinthaler M; Jung F; Empen K
Clin Hemorheol Microcirc; 2018; 70(4):381-389. PubMed ID: 30320566
[TBL] [Abstract][Full Text] [Related]
18. Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
Wijnbergen I; Helmes H; Tijssen J; Brueren G; Peels K; van Dantzig JM; Van' t Veer M; Koolen JJ; Pijls NH; Michels R
JACC Cardiovasc Interv; 2012 Mar; 5(3):313-22. PubMed ID: 22440498
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
20. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
